Ebola: Is there a hope from treatment with cardiovascular drugs?

International Journal of Cardiology

Volumn 177, Issue 2, 2014, Pages 524-526

  Patanè, Salvatore ^a  

^a Cardiologia Ospedale San Vincenzo   (Italy)

Author keywords

Amiodarone; Doxazosin; Pentoxifylline; Propranolol; Statin; Verapamil

Indexed keywords

CARDIOVASCULAR AGENT; PROPRANOLOL; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

BLOOD; HEMORRHAGIC FEVER, EBOLA; HUMAN; TREATMENT OUTCOME;

CARDIOVASCULAR AGENTS; HEMORRHAGIC FEVER, EBOLA; HUMANS; PROPRANOLOL; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84913594317     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.08.114     Document Type: Article

References (96)

1. M. Scarano, F. Pezzuoli, S. Patanè, G. Torrisi, G.M. Calvagna, and S. Patanè Cardiovascular implantable electronic device infective endocarditis Int J Cardiol 173 3 May 15 2014 e38 e39
2. M. Scarano, F. Pezzuoli, and S. Patanè Brucella infective endocarditis Int J Cardiol 172 3 Apr 1 2014 e509 e510
3. S. Patanè Is there a need for bacterial endocarditis prophylaxis in patients undergoing urological procedures? J Cardiovasc Transl Res 7 3 Apr 2014 369 371
4. S. Patanè Is there a need for bacterial endocarditis prophylaxis in patients undergoing gastrointestinal endoscopy? J Cardiovasc Transl Res 7 3 Apr 2014 372 374
5. G.M. Calvagna, and S. Patanè Severe staphylococcal sepsis in patient with permanent pacemaker Int J Cardiol 172 3 Apr 1 2014 e498 e501
6. G.M. Calvagna, F. Ceresa, and S. Patanè Subcutaneous implantable cardioverter-defibrillator in a young woman Int J Cardiol 175 2 Aug 1 2014 e30 e32
7. G.M. Calvagna, L. Costanzo, A. Di Pino, and S. Patanè Lead extraction in a young girl with dehiscence of a pacemaker implanted in the subpectoral region Int J Cardiol 176 3 Oct 20 2014 e135 e136
8. G.M. Calvagna, and S. Patanè Transvenous pacemaker lead extraction in infective endocarditis Int J Cardiol 176 2 Sep 20 2014 511 513
9. G.M. Calvagna, G. Torrisi, C. Giuffrida, and S. Patanè Pacemaker, Implantable cardioverter defibrillator, CRT, CRT-D, psychological difficulties and quality of life Int J Cardiol 174 2 Jun 15 2014 378 380
10. G.M. Calvagna, S. Patanè, P. Romeo, F. Ceresa, F. Sansone, and F. Patanè Embolization and retrieval of an anchoring sleeve during transvenous lead extraction Int J Cardiol 173 3 May 15 2014 e42 e44
11. R.O. Escárcega, J.J. Franco, B.C. Mani, A. Vyas, E.M. Tedaldi, and A.A. Bove Cardiovascular disease in patients with chronic human immunodeficiency virus infection Int J Cardiol 175 1 Jul 15 2014 1 7
12. A. Lozano, T. Bastante, and J. Salamanca Tako-tsubo cardiomyopathy triggered by Influenza A virus infection Int J Cardiol 174 2 Jun 15 2014 e52 e53
13. F. Peters, B.K. Khandheria, and S. Govender Human immunodeficiency virus and left ventricular noncompaction Int J Cardiol 168 5 Oct 12 2013 5099 5100
14. D.A. Brenner, M. Dela Cruz, and K. Thomas Emergency medical service utilization and door-to-balloon time for HIV-infected individuals with ST-elevation myocardial infarction Int J Cardiol 168 5 Oct 12 2013 4808 4809
15. Y. Xie, X. Zhang, and Z. Tian Preexposure to PM2.5 exacerbates acute viral myocarditis associated with Th17 cell Int J Cardiol 168 4 2013 Oct 9 3837 3845
16. W. Che, B. Liu, and F. Nie Association of TNF-α with left ventricular diastolic dysfunction in patients with hepatitis C virus infection Int J Cardiol 168 3 Oct 3 2013 2903 2904
17. Z.R. Estabragh, and M.A. Mamas The cardiovascular manifestations of influenza: a systematic review Int J Cardiol 167 6 Sep 10 2013 2397 2403 [Review]
18. L. Meng, Z. Zhang, K. Xu, and G. Qi HIV-1 gp120 induces autophagy in cardiomyocytes via the NMDA receptor Int J Cardiol 167 6 Sep 10 2013 2517 2523
19. C.C. Deluigi, P. Ong, and S. Hill ECG findings in comparison to cardiovascular MR imaging in viral myocarditis Int J Cardiol 165 1 Apr 30 2013 100 106
20. C.P. Oliveira, C.R. Kappel, and E.R. Siqueira Effects of hepatitis C virus on cardiovascular risk in infected patients: a comparative study Int J Cardiol 164 2 Apr 5 2013 221 226
21. C.H. Chiang, C.C. Huang, and W.L. Chan Herpes simplex virus infection and risk of atrial fibrillation: a nationwide study Int J Cardiol 164 2 Apr 5 2013 201 204
22. B. Wang, H. Qian, H. Yang, L. Xu, W. Xu, and J. Yan Regression of atherosclerosis plaques in apolipoprotein E-/- mice after lentivirus-mediated RNA interference of CD40 Int J Cardiol 163 1 Feb 10 2013 34 39
23. S. Patanè, F. Marte, M. Sturiale, G. Dattilo, and A. Albanese Myocarditis and cardiomyopathy HIV associated Int J Cardiol 146 3 Feb 3 2011 e56 e57
24. Feldmann H. Ebola A growing threat? N Engl J Med May 7.2014 [Epub ahead of print]
25. P. Aleksandrowicz, A. Marzi, and N. Biedenkopf Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis J Infect Dis 204 Suppl. 3 Nov 2011 S957 S967
26. S. Bhattacharyya, K.L. Warfield, G. Ruthel, S. Bavari, M.J. Aman, and T.J. Hope Ebolavirus uses clathrin-mediated endocytosis as an entry pathway Virology 401 1 May 25 2010 18 28
27. S.K. Rodal, G. Skretting, O. Garred, F. Vilhardt, B. van Deurs, and K. Sandvig Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles Mol Biol Cell 10 4 Apr 1999 961 974
28. P.Y. Liu, P.T. Lee, and W.T. Chang Evidence of pleiotropy by statins: Leukocyte Rho kinase (ROCK) activity and pretreated statin before percutaneous coronary interventions are clinical vascular outcome predictors Int J Cardiol 176 1 Sep 2014 250 253
29. G. Vilahur, L. Casani, and E. Peña HMG-CoA reductase inhibition prior reperfusion improves reparative fibrosis post-myocardial infarction in a preclinical experimental model Int J Cardiol 175 3 Aug 20 2014 528 538
30. L. Lei, X. Zhang, and Y. Mao Statin therapy and bone marrow CD34 + cell frequency in type 2 diabetes mellitus: a cross-sectional study Int J Cardiol 175 1 Jul 15 2014 214 216
31. G. Patti, M. Leoncini, and A. Toso Impact of high-dose statin pre-treatment and contrast-induced acute kidney injury on follow-up events in patients with acute coronary syndrome undergoing percutaneous coronary intervention Int J Cardiol 174 2 Jun 15 2014 440 441
32. C.Y. Chou, Y.C. Chou, Y.J. Chou, Y.F. Yang, and N. Huang Statin use and incident dementia: a nationwide cohort study of Taiwan Int J Cardiol 173 2 May 1 2014 305 310
33. A. Rossi, N. Gaibazzi, and R. Dandale Aortic valve sclerosis as a marker of coronary artery atherosclerosis; a multicenter study of a large population with a low prevalence of coronary artery disease Int J Cardiol 172 2 Mar 15 2014 364 367
34. A.N. Nowbar, G.D. Cole, M.J. Shun-Shin, J.A. Finegold, and D.P. Francis International RCT-based guidelines for use of preoperative stress testing and perioperative beta-blockers and statins in non-cardiac surgery Int J Cardiol 172 1 Mar 1 2014 138 143
35. G. Sardella, and L. Lucisano High dose statins should be used in all patients undergoing percutaneous coronary intervention Int J Cardiol 172 1 Mar 1 2014 e139
36. N. Takaoka, K. Tsujita, and K. Kaikita Comprehensive analysis of intravascular ultrasound and angiographic morphology of culprit lesions between ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome Int J Cardiol 171 3 Feb 15 2014 423 430
37. T. Hoshi, A. Sato, and Y. Kakefuda Preventive effect of statin pretreatment on contrast-induced acute kidney injury in patients undergoing coronary angioplasty: propensity score analysis from a multicenter registry Int J Cardiol 171 2 Feb 1 2014 243 249
38. N. Li, and Y.J. Yang Statin is a two-edged sword in liver enzyme Int J Cardiol 171 2 Feb 1 2014 e18
39. C.T. Ruff, D.L. Bhatt, and P.G. Steg REACH registry investigators. Statin is a two-edged sword in liver enzyme Int J Cardiol. 170 3 Jan 1 2014 413 418
40. M. Gliozzi, R. Walker, and S. Muscoli Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia Int J Cardiol 170 2 Dec 10 2013 140 145
41. R. Webster, A. Patel, and L. Billot SPACE collaboration. Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: the SPACE Collaboration Int J Cardiol. 170 1 Dec 5 2013 30 35
42. L. Grimaldi-Bensouda, M. Rossignol, and N. Danchin PGRx-MI study group. Real-life effectiveness of statins in the prevention of first acute coronary syndrome in France: a prospective observational study Int J Cardiol. 169 4 Nov 15 2013 271 275
43. D. Nikolic, M. Banach, and S. Nikfar Lipid and blood pressure meta-analysis collaboration group. A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? Int J Cardiol 168 6 Oct 15 2013 5437 5447
44. M.J. Tikkanen, R. Fayyad, and O. Faergeman IDEAL investigators. Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels Int J Cardiol. 168 4 Oct 9 2013 3846 3852
45. W. Koenig High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy Int J Cardiol 168 6 Oct 15 2013 5126 5134 [Review]
46. S. Han, X.M. Li, L.A. Mohammed Ali, N.K. Fu, D.X. Jin, and H.L. Cong Effect of short-term different statins loading dose on renal function and CI-AKI incidence in patients undergoing invasive coronary procedures Int J Cardiol 168 5 Oct 12 2013 5101 5103
47. H. Takagi, and T. Umemoto ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. Alice's evidence: reply to "Statins: a sine qua non of the management of patients with abdominal aortic aneurysms" Int J Cardiol 168 5 Oct 12 2013 5062
48. C.C. Huang, W.L. Chan, and Y.C. Chen The beneficial effects of statins in patients undergoing hemodialysis Int J Cardiol 168 4 Oct 9 2013 4155 4159
49. E.M. Ooi, P.H. Barrett, and G.F. Watts The extended abnormalities in lipoprotein metabolism in familial hypercholesterolemia: developing a new framework for future therapies Int J Cardiol 168 3 Oct 3 2013 1811 1818
50. Y.C. Liao, Y.C. Hsieh, and C.Y. Hung Statin therapy reduces the risk of ventricular arrhythmias, sudden cardiac death, and mortality in heart failure patients: a nationwide population-based cohort study Int J Cardiol 168 5 Oct 12 2013 4805 4807
51. H. Takagi, and T. Umemoto All-Literature Investigation of Cardiovascular Evidence (ALICE) Group. Low-density lipoprotein-dependent and independent effects of statins on prevention of major coronary events: meta-regression of randomized placebo-controlled trials Int J Cardiol 168 5 Oct 12 2013 4850 4853
52. U. Sartipy, E. Rampell, A.C. Carlsson, P. Wändell, and M.J. Holzmann Cardiovascular medication in relation to renal function after coronary artery bypass surgery Int J Cardiol 168 4 Oct 9 2013 4033 4038
53. K.I. Paraskevas, D.P. Mikhailidis, and A.D. Giannoukas Statins: a sine qua non of the management of patients with abdominal aortic aneurysms Int J Cardiol 168 4 Oct 9 2013 4528
54. M. Efremidis, K.P. Letsas, and L. Lioni The impact of vagotonic, adrenergic, and random type of paroxysmal atrial fibrillation on left atrial ablation outcomes Int J Cardiol 168 4 Oct 9 2013 4015 4018
55. A. Pirillo, and A.L. Catapano Omega-3 polyunsaturated fatty acids in the treatment of hypertriglyceridaemia Int J Cardiol 170 2 Suppl. 1 Dec 20 2013 S16 S20
56. G. Sardella, L. Lucisano, and M. Mancone Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial Int J Cardiol. 168 4 Oct 9 2013 3715 3720
57. C.Y. Hung, Y.C. Hsieh, and K.Y. Wang Efficacy of different statins for primary prevention of atrial fibrillation in male and female patients: a nationwide population-based cohort study Int J Cardiol. 168 4 Oct 9 2013 4367 4369
58. S. Palus, S. von Haehling, and V.C. Flach Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia Int J Cardiol 168 4 Oct 9 2013 3412 3418
59. M. Hu, S.S. Lui, G.T. Ko, and B. Tomlinson Do the lipid responses to rosuvastatin and atorvastatin differ between Chinese and Caucasians? Comparison of the DISCOVERY-Hong Kong study with other DISCOVERY studies Int J Cardiol 168 3 Oct 3 2013 3071 3073
60. J.G. Seo, S.H. Han, S.H. Kim, T.H. Ahn, and K.K. Koh Why do diabetic patients with multiple risk factors develop plaque progression rapidly despite interventional procedure and statin treatment Int J Cardiol 168 3 Oct 3 2013 2962 2964
61. M. Banach, S. Nikfar, and R. Rahimi Lipid and Blood Pressure Meta-Analysis Collaboration Group. The effects of statins on blood pressure in normotensive or hypertensive subjects - a meta-analysis of randomized controlled trials Int J Cardiol 168 3 Oct 3 2013 2816 2824
62. D. Zemánek, M. Branny, and L. Martinkovičová Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statintherapy. A randomized study Int J Cardiol. 168 3 Oct 3 2013 2494 2497
63. M. Thirunavukkarasu, V. Selvaraju, and N.R. Dunna Simvastatin treatment inhibits hypoxia inducible factor 1-alpha-(HIF-1alpha)-prolyl-4-hydroxylase 3 (PHD-3) and increases angiogenesis after myocardial infarction in streptozotocin-induced diabetic rat Int J Cardiol 168 3 Oct 3 2013 2474 2480
64. L. Mascitelli, and M.R. Goldstein Statins and diabetes: are numbers tortured on JUPITER? Int J Cardiol 168 1 Sep 20 2013 627 [Review]
65. S.M. Wörlund, M.W. Kurz, O. Hegland, K. Brønnick, P.S. Munk, and J.P. Larsen Treatment with statins improves long-term survival in individuals with carotid artery stenosis Int J Cardiol 168 1 Sep 20 2013 624 626
66. S.H. Han, P.C. Oh, S. Lim, R.H. Eckel, and K.K. Koh Comparative cardiometabolic effects of fibrates and omega-3 fatty acids Int J Cardiol 167 6 Sep 10 2013 2404 2411 [Review]
67. C.Y. Hung, C.H. Lin, and K.Y. Wang Dosage of statin, cardiovascular comorbidities, and risk of atrial fibrillation: a nationwide population-based cohort study Int J Cardiol 168 2 Sep 30 2013 1131 1136
68. S. Patanè Cardiotoxicity: anthracyclines and long term cancer survivors Int J Cardiol 176 3 Oct 20 2014 1326 1328
69. S. Patanè HERG-targeted therapy in both cancer and cardiovascular system with cardiovascular drugs Int J Cardiol 176 3 Oct 20 2014 1082 1085
70. S. Patanè ERBB1/EGFR and ERBB2 (HER2/neu) - targeted therapies in cancer and cardiovascular system with cardiovascular drugs Int J Cardiol 176 3 Oct 20 2014 1301 1303
71. S. Patanè Cancer multidrug resistance - targeted therapy in both cancer and cardiovascular system with cardiovascular drugs Int J Cardiol 176 3 Oct 20 2014 1306 1308
72. S. Patanè Breast cancer treatment cardioprotective strategies: the King is naked J Am Heart Assoc 2014 Published July 22,2014 http://www.jaha.ahajournals.org/content/3/2/e000665/reply
73. S. Patanè Cardiotoxicity: cisplatin and long term cancer survivors Int J Cardiol 175 1 Jul 15 2014 201 202
74. S. Patanè Insights into cardio-oncology: adrenergic receptor signaling and pathways in breast cancer Curr Med Res Opin Jun 26 2014 1 2 [http://informahealthcare. com/doi/full/10.1185/03007995.2014.932636]
75. S. Patanè Heart failure and breast cancer: emerging controversies regarding some cardioprotective strategies J Card Fail 20 6 Jun 2014 456 457
76. S. Patanè A challenge in cardiology: the oncosurgery Int J Cardiol 174 2 Jun 15 2014 411 412
77. M.F. Saeed, A.A. Kolokoltsov, T. Albrecht, and R.A. Davey Cellular entry of Ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes PLoS Pathog 6 9 Sep 16 2010 e1001110
78. Y. Haga, N. Miwa, S. Jahangeer, T. Okada, and S. Nakamura CtBP1/BARS is an activator of phospholipase D1 necessary for agonist-induced macropinocytosis EMBO J 28 9 May 6 2009 1197 1207
79. C.A. Baker, K. Desrosiers, and J.W. Dolan Propranolol inhibits hyphal development in Candida albicans Antimicrob Agents Chemother 46 11 Nov 2002 3617 3620
80. C. Otero, M. Linke, P. Sanchez, A. González, and I.A. Schaap Propranolol restricts the mobility of single EGF-receptors on the cell surface before their internalization PLoS One 8 12 Dec 9 2013 e83086
81. Y. Haga, N. Miwa, S. Jahangeer, T. Okada, and S. Nakamura CtBP1/BARS is an activator of phospholipase D1 necessary for agonist-induced macropinocytosis EMBO J 28 9 May 6 2009 1197 1207
82. A.K. McElroy, B.R. Erickson, and T.D. Flietstra Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome J Infect Dis 210 4 Aug 15 2014 558 566
83. W. Ruf Emerging roles of tissue factor in viral hemorrhagic fever Trends Immunol 25 9 Sep 2004 461 464 [Review]
84. D. Mechtcheriakova, G. Schabbauer, and M. Lucerna Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells FASEB J 15 1 Jan 2001 230 242
85. B.Q. Shen, D.Y. Lee, K.M. Cortopassi, L.A. Damico, and T.F. Zioncheck Vascular endothelial growth factor KDR receptor signaling potentiates tumor necrosis factor-induced tissue factor expression in endothelial cells J Biol Chem 276 7 Feb 16 2001 5281 5286 [Epub 2000 Oct 31]
86. 2 as a new player Vascul Pharmacol 62 2 Aug 2014 57 62 [Review]
87. A. Hoeben, B. Landuyt, M.S. Highley, H. Wildiers, A.T. Van Oosterom, and E.A. De Bruijn Vascular endothelial growth factor and angiogenesis Pharmacol Rev 56 Dec 2004 549 580 [Review]
88. S. Greenberger, and J. Bischoff Pathogenesis of infantile haemangioma Br J Dermatol 169 1 Jul 2013 12 19 [Review]
89. D. Tung, J. Ciallella, P.H. Cheung, and S. Saha Novel anti-inflammatory effects of doxazosin in rodent models of inflammation Pharmacology 91 1-2 2013 29 34
90. K. Keledjian, J.B. Garrison, and N. Kyprianou Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion J Cell Biochem 94 2 Feb 1 2005 374 388
91. K. Keledjian, and N. Kyprianou Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2 J Urol 169 3 Mar 2003 1150 1156
92. T.R. Cimato, and B.A. Palka Fractalkine (CX3CL1), GM-CSF and VEGF-a levels are reduced by statins in adult patients Clin Transl Med 3 14 Jun 14 2014
93. D. Salgado, T.E. Zabaleta, S. Hatch, M.R. Vega, and J. Rodriguez Use of pentoxifylline in treatment of children with dengue hemorrhagic fever Pediatr Infect Dis J 31 7 Jul 2012 771 773
94. R. Coimbra, W. Loomis, and H. Melbostad Role of hypertonic saline and pentoxifylline on neutrophil activation and tumor necrosis factor-alpha synthesis: a novel resuscitation strategy J Trauma 59 2 Aug 2005 257 264 [discussion 264-5]
95. H.J. Kim, and K.H. Lee The effectiveness of hypertonic saline and pentoxifylline (HTS-PTX) resuscitation in haemorrhagic shock and sepsis tissue injury: comparison with LR, HES, and LR-PTX treatments Injury 43 8 Aug 2012 1271 1276
96. G. Gehring, K. Rohrmann, and N. Atenchong The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry J Antimicrob Chemother 69 8 Aug 2014 2123 2131